SOD1-deficient mice exhibit key symptoms of human AMD, such as drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction, suggesting a critical role for SOD1 in protecting the retina from age-related degeneration and the potential of SOD1 gene-mediated AMD therapy [9]. This evidence concerns the gene SOD1 and age-related macular degeneration.